A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients-Reference-Cited by-同舟云学术

A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Published:2016-02-29 Issue:15 Volume:22 Page:3782-3790
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Rodriguez Pedro C.,Popa Xitllaly,Martínez Odeth,Mendoza Silvia,Santiesteban Eduardo,Crespo Tatiana,Amador Rosa M.,Fleytas Ricardo,Acosta Soraida C.,Otero Yanine,Romero Gala N.,de la Torre Ana,Cala Mireysi,Arzuaga Lina,Vello Loisel,Reyes Delmairis,Futiel Niurka,Sabates Teresa,Catala Mauricio,Flores Yoanna I.,Garcia Beatriz,Viada Carmen,Lorenzo-Luaces Patricia,Marrero Maria A.,Alonso Liuba,Parra Jenelin,Aguilera Nadia,Pomares Yaisel,Sierra Patricia,Rodríguez Gryssell,Mazorra Zaima,Lage Agustin,Crombet Tania,Neninger Elia

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. The progress of tumor vaccines clinical trials in non-small cell lung cancer;Clinical and Translational Oncology;2024-08-23

3. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

4. PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients;Vaccines;2024-07-24

5. Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances;Life Sciences;2024-06